Replies to post #233100 on Biotech Values

[ronpopeil]

$60 million offering

[DewDiligence]

GSK dumps IDYA collaboration:

https://finance.yahoo.com/news/ideaya-biosciences-inc-reports-second-100000560.html

Retained worldwide rights to IDE397, following GSK waiver of its option to an exclusive license to further develop and commercialize IDE397

Buried in 2Q22 financial release.